Advancement through adversity: how Covid-driven innovations are becoming best practices for pharmacovigilance
Pharmaceutical Technology
SEPTEMBER 7, 2022
Among the many effects the Covid-19 pandemic has had on the pharmaceutical industry is a substantial increase in the number of AEs being reported from drug trials, due to the fast-tracked development, approval and marketing of vaccines for the SARS-CoV-2 virus. Redesigning the translation process to increase efficiency.
52 
Let's personalize your content